NICE Ltd. (NCSYF) director Leo Apotheker details stock option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
NICE Ltd. director Leo Apotheker filed an initial ownership report showing multiple stock option grants over Ordinary Shares. The options cover various underlying share amounts with exercise prices such as 224.1800 and 144.9030 and expiration dates from 2026 through 2031, with some already fully vested and others vesting through September 30, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
12 transactions reported
Mixed
12 txns
Insider
Apotheker Leo
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
Holdings After Transaction:
Options — 2,785 shares (Direct)
Footnotes (1)
- The stock option is fully vested and currently exercisable. The stock option is vested and exercisable with respect to 746 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026. The stock option will vest on September 30, 2026.
FAQ
What does Leo Apotheker’s Form 3 filing for NICE Ltd. (NCSYF) show?
The Form 3 shows Leo Apotheker’s initial ownership in NICE Ltd. through multiple stock option grants on Ordinary Shares. It lists exercise prices, expiration dates, and vesting status, but reports no recent purchases or sales of shares.
What types of securities does Leo Apotheker hold in NICE Ltd. (NCSYF)?
Leo Apotheker holds stock options over NICE Ltd. Ordinary Shares. Each option line specifies an exercise price, such as 224.1800 or 144.9030, and an expiration date between 2026 and 2031, reflecting different option grants he has received.
Are Leo Apotheker’s NICE Ltd. options vested or still vesting?
Some options are fully vested and currently exercisable, while others vest over time. One grant tied to 746 Ordinary Shares is partly vested, with remaining portions vesting in three equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.
Do the reported NICE Ltd. (NCSYF) options for Leo Apotheker have specific expiration dates?
Yes, each option grant has a defined expiration date. The filing lists expirations ranging from September 10, 2026 through September 30, 2031, after which any unexercised options would no longer be available to convert into Ordinary Shares.
Does Leo Apotheker’s NICE Ltd. Form 3 indicate any recent stock trades?
The Form 3 does not indicate recent stock purchases or sales. It primarily records existing stock option holdings as of the reporting date, including their exercise prices, underlying Ordinary Shares, vesting status, and expiration schedule.